Mark A. Borden

Mark A. Borden is a Professor at the University of Colorado Boulder, specializing in biomedical engineering with a focus on microbubble and nanodrop technologies for diagnostic and therapeutic applications. His work bridges colloid science, ultrasound physics, and biomedical innovation. Key research areas include oxygen delivery systems, targeted drug delivery, and image-guided therapy for diseases like cancer and acute respiratory distress syndrome (ARDS).

He leads the Biomedical Engineering Program and has held roles on NIH review panels and international symposium committees. Awards include the NSF Career Award, NYSTAR James D. Watson Award, and multiple university service/research accolades. His lab has spun out companies Respirogen Inc. and Advanced Microbubbles LLC to commercialize medical technologies.

Publications highlight innovations in endoskeletal droplet design, photoacoustic imaging, and microbubble-based therapies. Research emphasizes molecular-level interfacial phenomena and translational medical devices, with applications in oncology, neurology, and critical care.